TerrAscend TSNDF
OTC TSNDF
$0.61 +0.05 (+8.56%)
At close: Aug 19, 2026 · 3:19 PM UTC

TerrAscend (TSNDF) Acquisitions (2022)

TerrAscend (TSNDF) posted quarterly Acquisitions of $24.7 million for Q1 2022.

TerrAscend (TSNDF) Acquisitions (2022) Analysis & Trends

TerrAscend (TSNDF) has reported Acquisitions for 1 consecutive years, with $24.7 million the latest figure, recorded in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn -
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn -
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn -
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 TerrAscend 187.35 Mn 145.23 Mn 36.25 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2022 24.72 Mn